Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. AntriaBio applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. AntriaBio is developing a product named AB101, a microsphere formulation of PEGylated human recombinant insulin.
Redwood City, CA, 94065